Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy-Reference-Cited by-同舟云学术

Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy

Published:2015-06 Issue:6 Volume:104 Page:1899-1908
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Narhi Linda O.,Corvari Vincent,Ripple Dean C.,Afonina Nataliya,Cecchini Irene,Defelippis Michael R.,Garidel Patrick,Herre Andrea,Koulov Atanas V.,Lubiniecki Tony,Mahler Hanns-Christian,Mangiagalli Paolo,Nesta Douglas,Perez-Ramirez Bernardo,Polozova Alla,Rossi Mara,Schmidt Roland,Simler Robert,Singh Satish,Spitznagel Thomas M.,Weiskopf Andrew,Wuchner Klaus

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference62 articles.

1. USP/NF general chapter <788>. Particulate matter in injections,2012

2. USP/NF general information <1787>,2013

3. Discrimination between silicone oil droplets and protein aggregates in biopharmaceuticals: A novel multiparametric image filter for subvisible particles in microflow imaging analysis;Strehl;Pharm Res,2012

4. Silicone oil-and agitation-induced aggregation of a monoclonal antibody in aqueous solution;Thirumangalathu;J Pharm Sci,2009

5. Basu P, Drishnan S, Thirmumangalathu R, Randolph TW, Carpenter JF. IgG1 aggregation and particle formation induced by silicone-water interfaces on siliconized borosilicate glass beads: A model for siliconized primary containers. J Pharm Sci 102:853–865.

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Destructive Analysis of Subvisible Particles with Mie-Scattering-Based Light Sheet Technology: System Development;Journal of Pharmaceutical Sciences;2024-09

2. Challenges at Submicron Particle Characterisation: A Case Study Using Nanoparticle Tracking Analysis (NTA);Journal of Pharmaceutical Innovation;2024-05-15

3. Evaluating Clinical Safety and Analytical Impact of Subvisible Silicone Oil Particles in Biopharmaceutical Products;Journal of Pharmaceutical Sciences;2024-05

4. A High Threshold of Biotherapeutic Aggregate Numbers is Needed to Induce an Immunogenic Response In Vitro, In Vivo, and in the Clinic;Pharmaceutical Research;2024-03-22

5. Shear stress as a driver of degradation for protein-based therapeutics: More accomplice than culprit;International Journal of Pharmaceutics;2024-01